Literature DB >> 17163171

Molecular imaging of cancer using PET and SPECT.

Andreas Kjaer1.   

Abstract

Molecular imaging allows for the study of molecular and cellular events in the living intact organism. The nuclear medicine methodologies of positron emission tomography (PET) and single photon emission computer tomography (SPECT) posses several advantages, which make them particularly suited for molecular imaging of cancer. Especially the possibility of a quick transfer of methods developed in animals to patients (translational research) is an important strength. This article will briefly discuss the newest applications and their importance and perspective in relation to the shift in paradigm in medicine towards more individualized treatment.

Entities:  

Mesh：

Year:  2006        PMID： 17163171

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  10 in total

Review 1.  Nanoparticles: a promising modality in the treatment of sarcomas.

Authors:  Michiro Susa; Lara Milane; Mansoor M Amiji; Francis J Hornicek; Zhenfeng Duan
Journal:  Pharm Res       Date:  2010-05-27       Impact factor: 4.200

Review 2.  Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Mark Kidd; Irvin Modlin; Kjell Öberg
Journal:  Nat Rev Clin Oncol       Date:  2016-06-07       Impact factor: 66.675

Review 3.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

Authors:  Severin Mairinger; Thomas Erker; Markus Muller; Oliver Langer
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

4.  PET/MRI in cancer patients: first experiences and vision from Copenhagen.

Authors:  Andreas Kjær; Annika Loft; Ian Law; Anne Kiil Berthelsen; Lise Borgwardt; Johan Löfgren; Camilla Bardram Johnbeck; Adam Espe Hansen; Sune Keller; Søren Holm; Liselotte Højgaard
Journal:  MAGMA       Date:  2012-12-25       Impact factor: 2.310

5.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

Authors:  Hao Hong; Yin Zhang; Jiangtao Sun; Weibo Cai
Journal:  Nano Today       Date:  2009-10-01       Impact factor: 20.722

Review 6.  Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors.

Authors:  Andreas Kjaer; Ulrich Knigge
Journal:  Scand J Gastroenterol       Date:  2015-06       Impact factor: 2.423

Review 7.  Molecular imaging of breast cancer: present and future directions.

Authors:  David Alcantara; Manuel Pernia Leal; Irene García-Bocanegra; Maria L García-Martín
Journal:  Front Chem       Date:  2014-12-18       Impact factor: 5.221

8.  Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.

Authors:  Hao Hong; Jiangtao Sun; Weibo Cai
Journal:  Biomark Insights       Date:  2008-09-23

9.  Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided 111In-labeled polymeric micelles.

Authors:  Chun-Chia Cheng; Chiung-Fang Huang; Ai-Sheng Ho; Cheng-Liang Peng; Chun-Chao Chang; Fu-Der Mai; Ling-Yun Chen; Tsai-Yueh Luo; Jungshan Chang
Journal:  Int J Nanomedicine       Date:  2013-04-10

10.  Imaging of hepatic drug transporters with [131I]6-β-iodomethyl-19-norcholesterol.

Authors:  Masato Kobayashi; Kodai Nishi; Asuka Mizutani; Tsuzumi Hokama; Miki Matsue; Tetsuya Tsujikawa; Takeo Nakanishi; Ryuichi Nishii; Ikumi Tamai; Keiichi Kawai
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.